As on Wednesday, PMV Pharmaceuticals Inc (NASDAQ: PMVP) got off with the flyer as it spiked 6.30% to $1.35, before settling in for the price of $1.27 at the close. Taking a more long-term approach, PMVP posted a 52-week range of $0.81-$1.82.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -14.06% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -14.06%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -35.38%. This publicly-traded company’s shares outstanding now amounts to $51.95 million, simultaneously with a float of $43.86 million. The organization now has a market capitalization sitting at $70.14 million. At the time of writing, stock’s 50-day Moving Average stood at $1.0750, while the 200-day Moving Average is $1.3048.
PMV Pharmaceuticals Inc (PMVP) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. PMV Pharmaceuticals Inc’s current insider ownership accounts for 15.58%, in contrast to 68.23% institutional ownership. According to the most recent insider trade that took place on Jul 01 ’25, this organization’s General Counsel & COO sold 23,151 shares at the rate of 1.06, making the entire transaction reach 24,651 in total value, affecting insider ownership by 98,695. Preceding that transaction, on Jul 01 ’25, Company’s Chief Development Officer sold 33,065 for 1.06, making the whole transaction’s value amount to 35,198. This particular insider is now the holder of 89,959 in total.
PMV Pharmaceuticals Inc (PMVP) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.
PMV Pharmaceuticals Inc’s EPS decrease for this current 12-month fiscal period is -35.38% and is forecasted to reach -1.76 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -15.79% through the next 5 years, which can be compared against the -14.06% growth it accomplished over the previous five years trading on the market.
PMV Pharmaceuticals Inc (NASDAQ: PMVP) Trading Performance Indicators
Let’s observe the current performance indicators for PMV Pharmaceuticals Inc (PMVP). It’s Quick Ratio in the last reported quarter now stands at 16.75.
In the same vein, PMVP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.17, a figure that is expected to reach -0.38 in the next quarter, and analysts are predicting that it will be -1.76 at the market close of one year from today.
Technical Analysis of PMV Pharmaceuticals Inc (PMVP)
Through scrutinizing the latest numbers posted by the [PMV Pharmaceuticals Inc, PMVP], it can be observed that its last 5-days Average volume of 0.34 million was better the volume of 0.2 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 51.25% While, its Average True Range was 64.39%.
Raw Stochastic average of PMV Pharmaceuticals Inc (PMVP) in the period of the previous 100 days is set at 87.10%, which indicates a major rise in contrast to 78.36% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0824 that was higher than 0.0762 volatility it exhibited in the past 100-days period.
